Lunge Systems: Pathways

The-risks-and-challenges-of-the-global-COVID-19-vaccine-rollout-vF.pdf?shouldIndex=f

auto-generated 31-Jan-2021

Risk Practice The risks and challenges of the global COVID-19- vaccine rollout A realistic assessment of the heroic effort to administer billions of doses of COVID-19 vaccines to an agonized global population is necessary the stakes could not be higher. This article was a collaborative effort by the global Risk Practice and authors from across the firm, including Gaurav Agrawal, Tara Azimi, Jennifer Heller, Pooja Kumar, Mihir Mysore, Parag Patel, Adam Sabow, Shubham Singhal, and Joseph Truesdale

Keywords

vaccines to an agonized vaccine united states vaccines risks doses challenges vaccine doses global

Sources: McKinsey

Pathway Demo and Download Data

You can download the excel file containing Categories, Goals, Measures and Actions. Please use Lunge App, to try the pathway data.

Download Pathway Data

Type: Strategies

Priority/ Function Areas: Business & Industrial Computers & Electronics Finance Internet & Telecom

Sectors/ Fields of Life: Manufacturing Wholesale & Retail Trade Information, Finance & Insurance Technical & Management Services

People/ Roles: Consumer Services Service Vendors Manufacturers Multi-Nationals Governments

Profiles: all rights a array this effort the manufacturers a issue its functions5 a map the capacity the authors each stakeholder this systems the vaccines the stakes this article the schedule the doses the effort the model each vial all areas the groups iz events analysis risks the safety firstdose administration its efforts the risks this rate the end a view the need the exhibit we estimates

Goals: require larger workforce build meet collaboration establish follow plans meet vaccine demand vaccinate source centers reevaluate own management optimize cold chain establish new partnerships execute realistic assessment produce covid19 vaccine purify resulting therapeutic mitigate storage concerns conduct validation runs forecast inventory management ensure effective rollout pose larger challenge challenge communications provider improve labor utilization transform systems infrastructure administer help vaccines need scheduling onboarding employ technology platforms have recognizable means increase lastmile transport highlight possible areas take common rawmaterials administer vaccine doses establish identify means grant done needs accelerate similar timelines manufacture materials fill expect dry supply show many stages seek approval contracts meet quality standards shut entire system develop administer distribute devise creative means enter ancillary supplies speed quality assure foster single view scale risk areas manage resource allocation challenge including systems follow defined plan rollout realistic assessment store scheduling preparing trace learn instances need emergent logistics asses perform ability complete medical experts produce new class meet unique demands prioritization vaccine system overtake putting consumption improve spoil likelihood affect certain segment create clear map minimize associated challenges face including hurdles

Measures: rapid delivery production lines compress gas devastate pandemic unique demands lastmile distribution current demand freezer capacity public adoption several vaccines good reliability possible approaches sufficient supply available volumes vaccine deployment great diversity several types improper refrigeration manufacture tower ancillary supplies herd immunity qualityassurance challenges ongoing regulators many organizations systematic intervals medical staff widespread adoption local administration global manufacturers enormous undertaking potential failure epidemiological end recent period vital challenges regular reviews local teams base approach recognizable means effective rollout annual vaccination spin-dry ice late section broad populations medical experts drug substance predictable supplier common requirements establish guidelines capable vials certain segment additional supplies historical wariness national regulators storage concerns many instances cold chain economic implications retail pharmacies 2nd dose possible areas technical workforce overall sample distribution risks global population fulltime vaccine several manufacturers long run entire system add hurdles upskil centers cdc vaccine unprecedented scale fulltime task datum locations great numbers global practice large challenge new facilities large amounts second doses accelerate vaccination regulatory approval novel platforms current level initial concerns pointofcare management realistic assessment seconddose allotments initial inventories postpandemic era high likelihood many doses practical steps technologytransfer timelines production levels relate restrictions high levels heroic effort fast project emergent logistics past months common rawmaterials agonize population good technology global demand major determinant local redistribution compel metrics administrator number technology platforms several approaches fillfinish materials acute concern legacy products dilute processes emergent threat intelligence awareness dedicate individuals far losses many stages massive deployment move systems short term many experts common model national view strict regulations source centers regulatory contracts query immunization resilient rawmaterials massive scale complex challenges mrnabased vaccines ice supply disruption events sufficient quantities develop countries covidcid1019 vaccines threat logistics global constraints own management icestylecggetty images lastmile transport advance source qualitative map many components vaccine demand spin-dry supply run runs high throughput short window central storage resource allocation design iis close coordination distinct vaccines healthcare worker muchexpanded ecosystem public education patient utilization define plan risk areas government institutions individual immunity second dose emerge crises positive tests administrative sites new partnerships local warehouse adverse events significant consequences viral vectors streamline sites first doses vulnerable populations clear map highlight areas lead organizations previous project fulltime personnel general public public administration train certification annual vaccinations cold storage manufacture yields qualify workforce good practices vaccine doses generate yields onsite storage administer record ultracold ice vaccine consumption much needs last year patient onboarding diplomatic challenges overall challenges validation runs immunity manufacturers critical areas use authorization final site new forms same time major data operational challenge limit resources critical importance common path risk reviews global collaboration requirement transport second appointments emergent storage manufacture recertification import management ancillary product vaccine administration specific characteristics global deployment inventory management global capacity global rollout logistic transport massive volumes several partnerships new assurance new standards dose appointments critical risks longterm storage schedule dose supplier plans track system streamline site current facilities high demand increase cooperation relevant organizations new means various locations healthcare workers associate risks cold assignment material vaccine pointofcare facilities emerge risks add period functional reviews such vaccines coldchain requirements vulnerable countries national allocation cold chains quality standards les access creative means key materials new class future capacity ongoing engagement critical need global exhibit devastate effects current immunity biomedical source administer events large workforce regulatory use first dose wastage risks similar timelines manufacture substance labor capacities potential impact optimistic dream approval contracts road map risk assessment precautionary period possible storage manufacture vaccine senior partner patient privacy authorization approval coldchain challenges future success schedule onboarding additional volumes long term pointofcare storage same wariness divert workers necessary loops global suppliers receive site inherent means critical roles sufficient capacity great strategies adverse event large sites single view labor utilization associate partner certain places clear roles short months critical supplies great emphasis popular confidence raw materials national institutions open communication human resources

Actions: upgrade systems restock coolers manufacture fill avoid overstockpiling reevaluate management maintain levels scale production require vaccines optimize chain facilitate adoption administer access receive vaccines delay production identify points reach immunity build confidence reach market administer billions expand capacity take rawmaterials reserve 10 prevent immunity speed assure manage allocation share awareness challenge track optimize utilization reduce risk challenge systems deploy vaccines outline approaches monitor spoilage monitor deployment conduct reviews establish partnerships meet demands shatter record trace instances complete experts build accountability rollout assessment require workforce establish plans establish means meet standards accelerate timelines build scenarios spoil institutions involve regulators divert allotments avoid losses need onboarding protect privacy ramp capacity demonstrate manufacturers manage risks build collaboration manage each develop standards asses likelihood reserve risks produce vials identify systems prevent risks use approach vaccinate patients streamline administration use types produce class shut system need vaccine release them administer 34 load mrna seek 3 putt emphasis face hurdles capture supplychain increase transport store preparing pave way asses progress commission systems hold doses1 ramp production establish practices grant needs vaccinate centers await dose include number affect segment reduce spoilage overtake consumption balance need purify therapeutic hold doses administer doses scale areas prioritize capacity bring volumes get time arrange childcare seek approval prioritization system spend hours conduct runs minimize challenges mitigate risks improve management express confidence represent worker seek contracts discuss each reach sites direct allocations pose challenge create timelines experience immunity receive dose distribute recording supplement percent have means improve utilization provide details manage issues receive authorization prepare vaccines prioritize efforts mitigate each demonstrate immunity devise means coldchain logistics ensure maintenance expect supply accelerate operations see light challenge provider increase resilience attend appointments establish standards track locations synchronize immunization execute assessment strain capacities meet demand cause contractual replenish ice play role develop distribute asses ability increase number pose challenges manage deployment reduce likelihood employ platforms refine practices understand throughput enhance speed test responses capture events boost levels maintain requirements highlight areas seek opportunities follow plan require volumes optimize lines end pandemic set cascade deliver vaccines improve likelihood prevent shortages administer vaccines scale access require forms foster view follow regulations create map forecast management require training receive doses show stages target reuters produce vaccine need logistics delay challenges refine certification transform infrastructure create redundancies scale manufacturing give cause supplement administration ensure rollout provide exhibit adapt operations mitigate concerns stockpile goods cause downtime require number enter supplies demonstrate complexity

Organization:

Find Pathways:

Keywords

Pathway Demo and Download Data